Ventyx Biosciences (NASDAQ:VTYX) announced the departure of Martin Auster, M.D., as CFO, effective August 30, 2024, and has initiated a search for his successor. The company’s SVP of finance, Ron Gonzales, CPA, MBA, has assumed the roles of interim principal financial officer and interim principal accounting officer for SEC reporting purposes.
“Marty has been a valued member of our executive team over these past three years,” said Raju Mohan, Ph.D., and chief executive officer of Ventyx. “I want to thank Marty for his contributions to Ventyx’s success, including leading the company through its initial public offering, managing financial and governance matters, and supporting investor relations. We wish him well in his future endeavors.”
In a statement, Dr. Auster said, “It has been a privilege to work as part of Ventyx’s leadership team, and I am proud of our accomplishments. I wish the company great success in the future.”
